EMA — authorised 3 July 2017
- Marketing authorisation holder: sanofi-aventis groupe
- Status: approved
🇪🇺 Dupixent in European Union
EMA authorised Dupixent on 3 July 2017
Marketing authorisation
Dupixent in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Dupixent approved in European Union?
Yes. EMA authorised it on 3 July 2017.
Who is the marketing authorisation holder for Dupixent in European Union?
sanofi-aventis groupe holds the EU marketing authorisation.